Ibuprofen Elac

Ibuprofen, the active ingredient in Ibuprofen Elac, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It provides analgesic, antipyretic, and anti‑inflammatory effects for the relief of pain, fever and inflammation in adults and children when appropriate. GNH USA supplies Ibuprofen Elac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen Elac is an NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes. - Pain: Provides analgesic relief for mild to moderate acute or chronic pain. - Fever: Lowers elevated body temperature associated with infectious or inflammatory conditions. - Inflammation: Decreases swelling and redness in soft tissues. - Arthritis: Alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome.

Before using Ibuprofen Elac, consider the following safety measures. - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Monitor renal function: use caution in individuals with impaired kidney function or dehydration. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use caution with cardiovascular disease: NSAIDs may increase thrombotic risk. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Ibuprofen Elac can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - Corticosteroids: increased ulceration potential.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible bleeding augmentation. - ACE inhibitors or ARBs: may impair renal function when combined. - Diuretics: can reduce renal perfusion and exacerbate fluid loss.